Latest Valuation News

Page 2 of 268
Argosy Property’s first-half statutory profit fell 73.5% to NZ$16.2 million after an NZ$18.1 million property revaluation provision, but occupancy and distributable income improved. A new NZ$750 million lending structure extends maturities and is expected to reduce annual funding costs by NZ$2 million.
Eva Park
Eva Park
18 Nov 2026
Infratil lifted FY27 operating EBITDAF guidance after a 28% first-half increase, led by data centres, renewables and One NZ. But the growth came with a NZ$247.8 million loss attributable to shareholders, a NZ$256 million incentive-fee provision and a sharp increase in capital spending.
Victor Sage
Victor Sage
18 Nov 2026
Sandon Capital Investments is promoting a 7.8% fully franked dividend yield and a 7.2% discount to pre-tax NTA, while acknowledging that QPM Energy’s administration cost its portfolio about 7%. The listed investment company says its long-term record and activist holdings continue to offer value, but recent performance has lagged key benchmarks.
Claire Turing
Claire Turing
17 Nov 2026
Actinogen Medical’s shares have been suspended while it completes analysis of additional data from its pivotal XanaMIA Alzheimer’s trial. The company expects trading to resume no later than 19 November unless the results announcement comes first.
Ada Torres
Ada Torres
17 Nov 2026
Delta Lithium’s preliminary study assigns Mt Ida a post-tax NPV of A$748 million, with an 11-year mine plan producing spodumene, lepidolite, rubidium and tantalum concentrates. The attractive headline economics come with a substantial caveat: the project still needs around A$500 million, further drilling and feasibility work before construction can be sanctioned.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Jade Gas has signed a binding mandate with an unnamed Tier 1 Hong Kong investment bank to sponsor its planned Hong Kong Stock Exchange IPO. The appointment moves the proposal into due diligence and application preparation, but approvals and market conditions still stand between the company and a listing.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Mayne Pharma has agreed to a A$6.40-a-share cash takeover by Hungary’s Gedeon Richter, valuing the company’s equity at approximately A$604 million. The recommended scheme still depends on regulatory clearances, shareholder and court approval, and completion of Mayne’s international business sale.
Victor Sage
Victor Sage
17 Nov 2026
Aldoro Resources says Wood Mackenzie has set a long-term forecast price of about US$6,900 per tonne for Kameelburg’s mixed rare earth carbonate, while a separate strontium carbonate stream could add another chemical product. The figures will feed into a Scoping Study that is nearing completion, but depend partly on purity targets not yet achieved.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Sigma Lithium has completed a US$125 million convertible bond issue, replacing roughly US$100 million of expensive secured debt due in 2027 with unsecured funding maturing in 2031. The refinancing lowers the stated coupon from 11.45% floating to 7.00% fixed and was increased by 25% after investor demand.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Tungsten Mining’s definitive feasibility study gives its Watershed project a pre-tax NPV of A$1.569 billion and targets first production in June 2027. The headline economics now face a more practical test: securing about A$255 million of remaining funding, binding offtake and a final investment decision.
Maxwell Dee
Maxwell Dee
17 Nov 2026
Investore Property lifted net profit 77% to NZ$22.6 million in the six months to 30 September, helped by property revaluations, while rental income and distributable profit also improved. The NZX-listed landlord reduced leverage after selling two Woolworths properties and reaffirmed its 6.50 cents per share FY27 dividend guidance, though AFFO declined as maintenance spending increased.
Eva Park
Eva Park
17 Nov 2026
Clime Capital has declared a 1.35 cent December quarter dividend as FY27 profit and portfolio returns remain positive. But the investment company is still working to resolve the valuation evidence issues behind its qualified FY26 audit opinion.
Claire Turing
Claire Turing
16 Nov 2026

Browse the archive

Full archive